‘Stop supplying immediately’: Pfizer recalls anaemia drug over 'fatal events'
Healthcare professionals have been urged to stop supplying Oxbryta “immediately” after new data revealed “an unfavourable imbalance” of “fatal events” and “acute painful crises” in patients on the drug.